- Revenue: $33.7 million, up 9% from $31.0 million in Q1'08
- Home Market: $14.4 million, up 36% from $10.5 million in Q1'08
- Gross Margin: 21%, up from 13% in Q1'08
- Company Announces International Distribution Agreement with Kimal plc
LAWRENCE, Mass., May 8 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced net revenue for the first quarter of 2009 of $33.7 million, an increase of 9 percent when compared with revenue of $31.0 million for the first quarter of 2008.
The Company's first quarter performance was primarily a result of continued execution against initiatives to drive broader market adoption in the Home market. The Company increased Home revenue by 36 percent to $14.4 million in the first quarter of 2009 when compared with revenues of $10.5 million for the first quarter of 2008. In the Company's other markets, Critical Care and In-Center revenues were $4.5 million and $14.9 million, respectively, for the first quarter of 2009.
"Our business has continued to perform well, consistent with our expectations and despite challenging economic conditions. We've delivered another quarter showing meaningful improvements in our business fundamentals," stated Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical, Inc. "We are pleased with the progress we've made on all our metrics and expect to make further advancements. We are also excited about our platforms for growth which now include expansion into the UK and Ireland via our new distribution agreement with Kimal plc."
Gross margin improved to 21 percent in the first quarter of 2009 as compared to 13 percent in the first quarter of 2008.
NxStage reported a net loss of $12.2
|SOURCE NxStage Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved